Lymelab Pharmasp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2021-02-18. Active
33 1240 5934 1111 0011 0362 1271
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
If the management board is a one-person management board, the sole member of the management board has the right to represent the company independently. If a multi-member management board has been appointed, each member of the management board is authorised to submit declarations on behalf of the company independently; however, incurring obligations or disposing of the company’s assets exceeding the amount of 2,000.00 złoty net (in words: two thousand złoty 00/100) requires the joint action of two members of the management board or one member of the management board and a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Damian Piotr Gorczyca (44) | 30 | $405.19 | 30% |
Andrzej Reszka (52) | 70 | $945.43 | 70% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Damian Piotr Gorczyca (44)  | Shareholder of a limited liability company, 1500.0 PLN | |
Andrzej Reszka (52) | Shareholder of a limited liability company, 3500.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com | ||
| VB IdeaP.S.A. | $44,631.63 | vbidea.pl | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Bio2materialssp. z o.o. | $14,121.59 | bio2materials.com | ||
| Nanostalsp. z o.o. | $8,607.48 | nanostal.com | ||
| IncellvuS.A. | $6,985.93 | incellvu.pl | ||
| NanotheaS.A. | $115.78 | nanothea.com | ||
| MolecureS.A. | $10.77 | molecure.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-06-26 | PKD change (Removed: 71.20.B, 72.11.Z, 72.19.Z; Added: 71.20.C, 72.10, 72.10.Z) | |
| 2020-11-25 | Entered in the register |
FAQ
Last updated: 2026-04-22